← Back to headlines
China Accepts Novo Nordisk Application for Oral Version of Wegovy
China’s National Medical Products Administration has officially accepted Novo Nordisk’s regulatory filing for an oral formulation of its popular weight-management drug Wegovy. The approval process could significantly expand patient access to the medication in the world’s second-largest pharmaceutical market.
27 Aug, 03:47 — 27 Aug, 04:49
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (24/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left
Center2
Center (2)
investing-comReuters
Right
Far R
Geographic diversity— 2 regions9/34
US1Intl1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
ReutersVery High5d ago
China's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
Read full article →investing-com5d ago
China’s drug regulator accepts Novo Nordisk’s application for oral Wegovy
By Reuters
Read full article →Coverage Timeline
First report: Reuters · 27 Aug, 03:47|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
Related Stories
Shein Shares Plunge on Hong Kong Stock Exchange Debut Amid Growth Concerns
28m ago
South Korea Reports Record August Export Surge Driven by Semiconductor Demand
30m ago
South Korean and Turkish Defense Firms Climb Global Industry Rankings
33m ago
Apple Accuses OpenAI of Misusing Confidential Data and Spoliating Evidence
38m ago